Agent Skills
› brycewang-stanford/Awesome-Journal-Skills
› american-journal-of-respiratory-and-critical-care-medicine
american-journal-of-respiratory-and-critical-care-medicine
GitHub用于评估呼吸、重症或睡眠研究是否适合投稿至AJRCCM。提供期刊定位、选题范围、证据标准及报告规范等投稿匹配度分析，辅助作者进行稿件框架调整与 venue 选择，非临床建议。
Trigger Scenarios
作者指定向AJRCCM或“蓝刊”投稿呼吸/重症/睡眠领域研究
需将基础或转化医学研究重构为机制或改变临床实践的问题
在AJRCCM、Lancet Respiratory Medicine和Critical Care Medicine间选择目标期刊
查询该期刊对各类研究的报告指南、注册要求及动物实验期望
Install
npx skills add brycewang-stanford/Awesome-Journal-Skills --skill american-journal-of-respiratory-and-critical-care-medicine -g -y
SKILL.md
Frontmatter
{
"name": "american-journal-of-respiratory-and-critical-care-medicine",
"description": "Use when targeting the American Journal of Respiratory and Critical Care Medicine or deciding whether a respiratory, critical-care, or sleep study fits this venue. Encodes the journal's fit across clinical-translational-basic science, the mechanistic and evidence bar, reporting-guideline and registration requirements, ATS house style, official-submission re-check, and desk-reject heuristics. Venue-fit aid only, not clinical advice."
}
American Journal of Respiratory and Critical Care Medicine (american-journal-of-respiratory-and-critical-care-medicine)
Journal positioning
The American Journal of Respiratory and Critical Care Medicine (AJRCCM, the American Thoracic Society "Blue Journal") is the ATS flagship, publishing high-impact research across the full respiratory–critical-care–sleep spectrum and across the full evidence spectrum: definitive clinical trials and cohorts, translational mechanism, and basic pulmonary, vascular, and immunologic science. Its defining expectation is a conceptually important advance in lung biology, respiratory/critical-illness disease mechanism, or pulmonary/sleep clinical care — not an incremental single-center series or a descriptive cohort with no mechanistic or practice-changing yield. Because it spans bench to bedside, AJRCCM tolerates basic and translational work that a purely clinical respiratory journal would not. This skill is a fit / venue-selection / re-framing aid; it is not clinical or regulatory advice and does not replace the journal's current instructions for authors. Before submitting, re-check the live AJRCCM author instructions.
When to trigger
- The author names AJRCCM or the "Blue Journal" for a respiratory, pulmonary-vascular, critical-care, or sleep-medicine study and wants a fit/framing check.
- A clinical, translational, or basic-science lung study must be re-framed around a mechanism or a practice-changing pulmonary/critical-illness question.
- The author is choosing between AJRCCM, The Lancet Respiratory Medicine (clinical/trial high-impact), and Critical Care Medicine (ICU-focused).
- The author needs the journal's reporting-guideline, registration, and basic/animal-study expectations spanning bench-to-bedside work.
Scope & topic fit
- Adult and pediatric pulmonary disease: asthma, COPD, ILD/pulmonary fibrosis, cystic fibrosis, infection, and pulmonary vascular disease (PAH).
- Critical-care and acute respiratory illness: ARDS, mechanical ventilation, acute lung injury — with mechanistic or outcome rigor.
- Sleep and circadian medicine: sleep-disordered breathing and its physiologic or outcome consequences.
- Translational and basic lung science: lung development, immunology, epithelial and endothelial biology, and animal/cell models that illuminate human disease.
- Clinical trials, large cohorts, and biomarker studies with respiratory or critical-illness endpoints.
- Pulmonary physiology, imaging, and -omics studies that establish a disease mechanism or a new biological insight.
Method & evidence bar
- Clinical studies must be adequately powered with prespecified, patient-centered endpoints; trials require prospective registration and the registration number.
- The applicable reporting guideline and checklist are expected: CONSORT for trials, STROBE for observational work, PRISMA for systematic reviews, ARRIVE for animal studies.
- Translational/basic work must show rigorous controls, biological replication, blinded and randomized animal experiments where applicable, and reagent/model validation.
- Mechanistic claims need direct causal evidence (perturbation, not correlation alone); human relevance should be anchored to patient samples or validated models.
- Effect estimates need confidence intervals and absolute as well as relative measures; causal language must match the design and the species/model studied.
- Sample-size, replication, and statistical-analysis plans must be explicit for both clinical and laboratory studies.
Structure & house style
- ATS format with a structured abstract and an "At a Glance Commentary" / scientific knowledge statement; re-check current article types (Original Article, Concise Clinical Study, etc.) and limits on the live guide.
- The introduction frames the biological or clinical gap; the discussion states the mechanistic insight or practice implication plainly and bounds overreach.
- A CONSORT/STROBE/PRISMA flow diagram is expected for the relevant clinical design; animal studies report ARRIVE-aligned design detail.
- Figures must show representative data with statistics, N, and replication; an online supplement carries full methods, the protocol/SAP, and additional experiments.
Official-submission checklist
- Before giving submission-ready advice, read
../../resources/source-basis.mdand../../resources/official-source-map.md; start from the ICMJE/EQUATOR and ATS anchors, then cite the current AJRCCM page you checked. - Search the live site for "AJRCCM American Thoracic Society instructions for authors" and follow the current version.
- Re-check article types, abstract and At-a-Glance format, and word/figure/reference limits.
- Confirm trial registration, the reporting checklist (CONSORT/STROBE/PRISMA/ARRIVE), data/code-availability, and protocol/SAP submission.
- Re-check IRB/ethics and consent, animal-care/IACUC approval for laboratory work, ICMJE authorship and conflict-of-interest disclosure, funding, and AI-use disclosure.
- If the live official instructions conflict with this skill, the official instructions win.
Pre-submission self-check
- The study delivers a clear mechanistic insight or practice-changing respiratory/critical-illness finding.
- Clinical endpoints are prespecified and powered; trials are registered with the number in the manuscript.
- The correct reporting checklist (CONSORT/STROBE/PRISMA/ARRIVE) is completed and attached.
- Basic/translational work shows controls, biological replication, and model validation.
- Mechanistic claims rest on perturbation evidence and are anchored to human relevance.
- IRB/consent, IACUC (if animal), ICMJE disclosures, and a data-availability statement are prepared.
Common desk-reject triggers
- Single-center descriptive series or registry slice with no mechanism and no practice change.
- Association-only biomarker or -omics studies with no validation cohort or functional follow-up.
- Animal/cell work without disease relevance, replication, or ARRIVE-aligned rigor.
- Missing trial registration, protocol, or the required reporting checklist.
- Narrow ICU-management question better served by an intensive-care journal, or a purely clinical trial with limited mechanistic depth.
Re-routing decision
- High-impact respiratory clinical trial without a mechanistic core →
the-lancet-respiratory-medicine. - ICU-management / organ-support focus over pulmonary biology →
critical-care-medicine. - Perioperative respiratory or sedation/ventilation in surgery →
anesthesiology/jama-surgery. - Broad practice-changing significance beyond pulmonology → general medicine (
jama/ NEJM / The Lancet in the natural-science bundle). - Pure basic immunology/cell biology with no lung-disease anchor → a basic-science venue in the natural-science bundle.
Output format
[Fit] High / Medium / Low (one-line reason)
[Target] American Journal of Respiratory and Critical Care Medicine (ATS Blue Journal)
[Specialty tags] <pulmonary / pulmonary-vascular / critical-care / sleep + clinical/translational/basic>
[Study design / reporting guideline] <RCT-CONSORT / cohort-STROBE / review-PRISMA / animal-ARRIVE>
[Method/evidence] <power, mechanism, controls/replication, registration>
[Top risk] <the single most likely reason for rejection>
[Official items to re-check] <article type / registration / checklist / IACUC / ethics / disclosures>
[Re-route suggestion] <if not a fit, a better-matched venue>
Version History
- 1839142 Current 2026-07-05 12:35
